Regenerative options may include: Platelet-rich plasma, or PRP Platelet-fibrin products, or PFP Micro-fragmented adipose tissue, or MFAT Epidural spinal injections Each therapy works differently
Assuming Eli Lilly follows a similar timeline to tirzepatide, the earliest possible FDA approval for retatrutide would likely occur in late 2027 or 2028, depending on Phase 3 trial results and regulatory review timelines
This post explains why protein matters so much during GLP1 therapy, how much you should aim for, and practical ways to meet your goals even on low-appetite days
But Lilly said 11% of participants on the highest retatrutide dose quit the study because of gastrointestinal side effectsa bigger dropout rate than for less powerful obesity drugs
Nature Metabolism, 5(6), 945-954
Do not warm Emgality by using a heat source such as hot water or a microwave